Dawang Zhou
- Molecular Biology top 2%
- Cell Biology top 0.2%
- Immunology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Topics
- Hippo pathway signaling and YAP/TAZ (24 papers)Wnt/β-catenin signaling in development and cancer (13 papers)Alzheimer's disease research and treatments (6 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Dawang Zhou
53 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 3.9k
- Cell Biology 3.1k
- Immunology 763
- Oncology 643
- Cancer Research 548
Countries citing papers authored by Dawang Zhou
This map shows the geographic impact of Dawang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawang Zhou more than expected).
Fields of papers citing papers by Dawang Zhou
This network shows the impact of papers produced by Dawang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawang Zhou. The network helps show where Dawang Zhou may publish in the future.
Co-authorship network of co-authors of Dawang Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Dawang Zhou. A scholar is included among the top collaborators of Dawang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawang Zhou. Dawang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 52 | |
| 4 | 89 | |
| 5 | The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8breakdown → | 270 |
| 6 | Silencing circSLC19A1 Inhibits Prostate Cancer Cell Proliferation, Migration and Invasion Through Regulating miR-326/MAPK1 Axis | 1 |
| 7 | 123 | |
| 8 | 226 | |
| 9 | 93 | |
| 10 | 29 | |
| 11 | 86 | |
| 12 | 39 | |
| 13 | 117 | |
| 14 | 19 | |
| 15 | 27 | |
| 16 | 377 | |
| 17 | 91 | |
| 18 | 102 | |
| 19 | 51 | |
| 20 | 51 |
About Dawang Zhou
Dawang Zhou is a scholar working on Cell Biology, Molecular Biology and Physiology, having authored 55 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (24 papers), Wnt/β-catenin signaling in development and cancer (13 papers) and Alzheimer's disease research and treatments (6 papers). The work is most often cited by research in Cell Biology (3.1k citations), Molecular Biology (3.9k citations) and Cancer Research (548 citations). Dawang Zhou has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Joseph Avruch, Nabeel Bardeesy, Yi Yin, Lanfen Chen, Hang‐zi Chen, Qiao Wu, Fan Xia, Jiahuai Han, Thijn R. Brummelkamp and Oktay Kirak. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.